Your Account
Sort
Categories
- #EMSPVirtual2021
- Annual Report
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Project Updates
- Stakeholder Events
- Uncategorized
- Young People with MS
‘EBV-MS’ research funded by Horizon Europe kick-starts in Norway
EMSP participated in the kick-off meeting of one its newly received Horizon EU-funded projects: EBV-MS. In a hybrid event on…
Multiple Sclerosis – Toward Sustainable and Healthier Systems in Europe | EMSP Annual Conference 2024
This year, the European Multiple Sclerosis Platform’s Annual Conference will take place in Brussels on 19 and 20 April with…
Empowering MS Societies – Building Effective Registries for Improved Care and Advocacy: A Membership Capacity Building Workshop with MS Data Alliance
As part of its Membership Capacity Building (MCB) Programme, the European Multiple Sclerosis Platform (EMSP), in close collaboration and leadership…
EU funds research into causes and new therapies for multiple sclerosis
The progression of multiple sclerosis (MS) can usually be slowed down with medication, but a cure is currently not possible….
EMSP @ ECTRIMS 2023 – Key takeaways
Introduction EMSP at ECTRIMS 2023 Highlights of sessions attended by EMSP delegates Plenary session Epstein-Barr virus (EBV) and MS Transition…
Ground-breaking research with potential for MS treatments launched
Targeting Epstein-Barr virus to treat and prevent MS Researchers launch pioneering EU funded research initiative to uncover role of Epstein-Barr…
